Common Contracts
33 similar Change in Control Severance Agreement contracts by Immunogen Inc, WESTMORELAND COAL Co, ImmunoGen, Inc.
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • November 2nd, 2023 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 18th day of September, 2023 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Lauren White (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 1st, 2023 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 5th day of January, 2021 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Renee Lentini (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 28th, 2022 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 15th day of November, 2021 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Kristen Harrington-Smith (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 9th, 2018 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 23rd day of April, 2018 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Blaine H. McKee (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Theresa G. Wingrove (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Mark J. Enyedy (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Peter Williams (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Thomas Ryll (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Craig Barrows (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and David B. Johnston (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Anna Berkenblit (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 5th, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 31st day of March, 2017 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Richard J. Gregory (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 29th, 2017 • WESTMORELAND COAL Co • Bituminous coal & lignite surface mining • Colorado
This Agreement is entered into as of March 14, 2017 (the “Effective Date”) by and between Westmoreland Coal Company, a Delaware corporation (the “Company”), and Gary A. Kohn (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 3rd, 2017 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of March, 2015 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Anna Berkenblit (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 25th, 2016 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 16th day of May, 2016 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Mark Enyedy (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 14th, 2016 • WESTMORELAND COAL Co • Bituminous coal & lignite surface mining • Colorado
This Agreement is entered into as of December 10, 2015 (the “Effective Date”) by and between Westmoreland Coal Company, a Delaware corporation (the “Company”), and Jason W. Veenstra (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • April 28th, 2015 • WESTMORELAND COAL Co • Bituminous coal & lignite surface mining • Colorado
This Agreement is entered into as of February 25, 2015 (the “Effective Date”) by and between Westmoreland Coal Company, a Delaware corporation (the “Company”), and Joseph Micheletti (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • April 28th, 2015 • WESTMORELAND COAL Co • Bituminous coal & lignite surface mining • Colorado
This Agreement is entered into as of February 25, 2015 (the “Effective Date”) by and between Westmoreland Coal Company, a Delaware corporation (the “Company”), and Jennifer Grafton (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • April 28th, 2015 • WESTMORELAND COAL Co • Bituminous coal & lignite surface mining • Colorado
This Agreement is entered into as of February 25, 2015 (the “Effective Date”) by and between Westmoreland Coal Company, a Delaware corporation (the “Company”), and Kevin Paprzycki (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • April 28th, 2015 • WESTMORELAND COAL Co • Bituminous coal & lignite surface mining • Colorado
This Agreement is entered into as of February 25, 2015 (the “Effective Date”) by and between Westmoreland Coal Company, a Delaware corporation (the “Company”), and John Schadan (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • April 28th, 2015 • WESTMORELAND COAL Co • Bituminous coal & lignite surface mining • Colorado
This Agreement is entered into as of February 25, 2015 (the “Effective Date”) by and between Westmoreland Coal Company, a Delaware corporation (the “Company”), and Keith Alessi (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 5th, 2015 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 5th day of January, 2015 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Richard J. Gregory (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • October 30th, 2014 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 15th day of September, 2014 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Sandra E. Poole (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 2nd, 2014 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 20th day of February, 2014 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Ellie Harrison (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 5th, 2014 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of December, 2013 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and David B. Johnston (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Charles Q. Morris (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Daniel M. Junius (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Craig Barrows (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Theresa G. Wingrove (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Peter Williams (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and James J. O’Leary (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and John M. Lambert (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • January 30th, 2013 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2012 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Gregory D. Perry (the “Executive”).
